Pendal Group LTD Vertex Pharmaceuticals Inc Transaction History

Pendal Group LTD

$12.2 Billion
Q4 2022

A detailed history of Pendal Group LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pendal Group LTD holds 297,723 shares of VRTX stock, worth $119 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

297,723

Previous 297,298 0.14%

Holding current value

$119 Million

Previous $86.1 Million 0.12%

% of portfolio

0.7%

Previous 0.84%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	BUY	$285.76 - $321.48 $121,448 - $136,629	425 Added 0.14%	297,723 $0
Q3 2022 Oct 18, 2022	SELL	$273.83 - $305.53 $16.8 Million - $18.8 Million	-61,498 Reduced 17.14%	297,298 $86.1 Million
Q2 2022 Jul 25, 2022	BUY	$234.96 - $292.55 $83.7 Million - $104 Million	356,424 Added 15026.31%	358,796 $101 Million
Q1 2022 Apr 25, 2022	SELL	$221.42 - $260.97 $2,657 - $3,131	-12 Reduced 0.5%	2,372 $619,000
Q4 2021 Jan 18, 2022	SELL	$177.01 - $223.45 $169,929 - $214,512	-960 Reduced 28.71%	2,384 $524,000
Q3 2021 Nov 05, 2021	SELL	$181.39 - $202.99 $2.57 Million - $2.88 Million	-14,188 Reduced 80.93%	3,344 $607,000
Q2 2021 Jul 28, 2021	SELL	$187.49 - $221.1 $5,624 - $6,633	-30 Reduced 0.17%	17,532 $3.54 Million
Q1 2021 May 24, 2021	BUY	$207.02 - $241.31 $3.64 Million - $4.24 Million	17,562 New	17,562 $3.77 Million
Q1 2021 May 03, 2021	SELL	$207.02 - $241.31 $2.68 Million - $3.13 Million	-12,953 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$207.01 - $276.09 $1.19 Million - $1.58 Million	5,737 Added 79.5%	12,953 $3.06 Million
Q3 2020 Nov 02, 2020	SELL	$255.65 - $303.1 $139,073 - $164,886	-544 Reduced 7.01%	7,216 $1.96 Million
Q2 2020 Aug 07, 2020	BUY	$225.48 - $295.8 $138,219 - $181,325	613 Added 8.58%	7,760 $2.25 Million
Q1 2020 May 04, 2020	BUY	$199.77 - $247.81 $367,776 - $456,218	1,841 Added 34.7%	7,147 $1.7 Million
Q4 2019 Feb 06, 2020	BUY	$166.71 - $223.91 $884,563 - $1.19 Million	5,306 New	5,306 $1.16 Million
Q4 2018 Jan 30, 2019	SELL	$151.91 - $192.21 $7.05 Million - $8.92 Million	-46,397 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$167.73 - $192.74 $612,046 - $703,308	3,649 Added 8.54%	46,397 $0
Q2 2018 Jul 18, 2018	SELL	$145.72 - $169.96 $3.14 Million - $3.66 Million	-21,554 Reduced 33.52%	42,748 $0
Q1 2018 May 08, 2018	SELL	$151.6 - $177.13 $795,142 - $929,046	-5,245 Reduced 7.54%	64,302 $0
Q4 2017 Feb 06, 2018	SELL	$137.28 - $155.55 $2.19 Million - $2.48 Million	-15,965 Reduced 18.67%	69,547 $0
Q3 2017 Nov 01, 2017	BUY	$148.13 - $162.24 $6.39 Million - $7 Million	43,125 Added 101.74%	85,512 $0
Q2 2017 Aug 11, 2017	BUY	N/A	42,387	42,387 $0

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $103B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Account